Autonomic function in patients with Duchenne muscular dystrophy

Pediatrics International

Volumn 51, Issue 1, 2009, Pages 33-40

  Inoue, Miki ^a   Mori, Kazuhiro ^a   Hayabuchi, Yasunobu ^a   Tatara, Katsunori ^b   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Yoshinogawa   (Japan)

Author keywords

Autonomic function; Duchenne muscular dystrophy; Mean heart rate at night

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM; CHILD; HEART RATE; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 60849102822     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02656.x     Document Type: Article

References (23)

1. Ishikawa Y, Bach JR, Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am. Heart J. 1999 137 : 895 902.
2. Duboc D, Meune C, Lerebours G et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J. Am. Coll. Cardiol. 2005 45 : 855 7.
3. Giglio V, Pasceri V, Messano L et al. Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J. Am. Coll. Cardiol. 2003 42 : 309 16.
4. Mori K, Edagawa T, Inoue M et al. Peak negative myocardial velocity gradient and wall-thickening velocity during early diastole are noninvasive parameters of left ventricular diastolic function in patients with Duchenne's progressive muscular dystrophy. J. Am. Soc. Echocardiogr. 2004 17 : 322 9.
5. Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr. Cardiol. 2002 23 : 160 66.
6. Kearney MT, Fox KAA, Lee AJ et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J. Am. Coll. Cardiol. 2002 40 : 1801 8.
7. La Rovere MT, Pinna GD, Maestri R et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003 107 : 565 70.
8. Lanza GA, Russo AD, Giglio V et al. Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: Relationship to myocardial and respiratory function. Am. Heart J. 2001 141 : 808 12.
9. Yotsukura M, Fujii K, Katayama A et al. Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy. Am. Heart J. 1998 136 : 289 96.
10. Yotsukura M, Sasaki K, Kachi E, Sasaki A, Ishihara T, Ishikawa K. Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy. Am. J. Cardiol. 1995 76 : 947 51.
11. Bach JR. The Natural Histories. Guide to the Evaluation and Management of Neuromuscular Disease. Hanley and Belfus, Philadelphia, 1999.
12. Malik M, Camm AJ, Bigger JT et al. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996 93 : 1043 65.
13. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: A measure of cardiac autonomic tone. Am. Heart J. 1994 127 : 1376 81.
14. van Ravenswaaij-Arts CMA, Kollee LAA, Hopman JCW, Stoelinga GBA, van Geijn HP. Heart rate variability. Ann. Intern. Med. 1993 118 : 436 47.
15. Otsuka K. A Normal Value of Heart Rate Variability from 24-hour Ambulatory Electrocardiogram. Chronome and Janus Medicine. Medical Review, Tokyo, 1998.
16. Mortara A, Krum H, Sondermejer H et al. Heart rate variability in the LF band is closely related to BNP levels in heart failure. Data from the multicenter Valsartan Heart Failure Trial (Val-HeFT). Eur. Heart J. 2006 27 : 15 18.
17. Ponikowski P, Anker SD, Chua TP et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1997 79 : 1645 50.
18. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur. Heart J. 2005 26 : 967 74.
19. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004 109 : 120 24.
20. f current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004 109 : 1674 9.
21. Sliwa K, Norton GR, Kone N et al. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J. Am. Coll. Cardiol. 2004 44 : 1825 30.
22. Simonds AK. Recent advance in respiratory care for neuromuscular disease. Chest 2006 130 : 1879 86.
23. American Academy of Pediatrics, Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005 116 : 1569 73.